Neoadjuvant atezolizumab in resectable NSCLC patients: Updated clinical and immunophenotyping results from a multicenter trial Meeting Abstract
| Authors: | Oezkan, F.; He, K.; Owen, D. H.; Pietrzak, M.; Rusch, V. W.; Chaft, J. E.; Kitzler, R.; Nicholas, A.; Schulze, K.; Johnson, A.; Phan, S.; Bunn, P. A.; Kris, M. G.; Kwiatkowski, D. J.; Johnson, B. E.; Wistuba, I. I.; Lee, J. M.; Hirsch, F. R.; Lozanski, G.; Carbone, D. P. |
| Abstract Title: | Neoadjuvant atezolizumab in resectable NSCLC patients: Updated clinical and immunophenotyping results from a multicenter trial |
| Meeting Title: | 2019 ASCO-SITC Clinical Immuno-Oncology Symposium |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 37 |
| Issue: | 8 Suppl. |
| Meeting Dates: | 2019 Feb 28-Mar 2 |
| Meeting Location: | San Francisco, CA |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2019-03-10 |
| Language: | English |
| ACCESSION: | WOS:000489109600105 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2019.37.8_suppl.99 |
| Notes: | Meeting Abstract: 99 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
